Online adaptive dose restoration in intensity modulated proton therapy of lung cancer to account for inter-fractional density changes
- PMID: 33458323
- PMCID: PMC7807540
- DOI: 10.1016/j.phro.2020.06.004
Online adaptive dose restoration in intensity modulated proton therapy of lung cancer to account for inter-fractional density changes
Abstract
Background and purpose: In proton therapy, inter-fractional density changes can severely compromise the effective delivery of the planned dose. Such dose distortion effects can be accounted for by treatment plan adaptation, that requires considerable automation for widespread implementation in clinics. In this study, the clinical benefit of an automatic online adaptive strategy called dose restoration (DR) was investigated. Our objective was to assess to what extent DR could replace the need for a comprehensive offline adaptive strategy.
Materials and methods: The fully automatic and robust DR workflow was evaluated in a cohort of 14 lung IMPT patients that had a planning-CT and two repeated 4D-CTs (rCT1,rCT2). Initial plans were generated using 4D-robust optimization (including breathing-motion, setup and range errors). DR relied on isodose contours generated from the initial dose and associated patient specific weighted objectives to mimic this initial dose in repeated-CTs. These isodose contours, with their corresponding objectives, were used during re-optimization to compensate proton range distortions disregarding re-contouring. Robustness evaluations were performed for the initial, not-adapted and restored (adapted) plans.
Results: The resulting DVH-bands showed overall improvement in DVH metrics and robustness levels for restored plans, with respect to not-adapted plans. According to CTV coverage criteria (D95%>95%Dprescription) in not-adapted plans, 35% (5/14) of the cases needed offline adaptation. After DR, Median(D95%) was increased by 1.1 [IQR,0.4] Gy and only one patient out of 14 (7%) still needed offline adaptation because of important anatomical changes.
Conclusions: DR has the potential to improve CTV coverage and reduce offline adaptation rate.
Keywords: Adaptive proton therapy; Adaptive radiation therapy; Automated adaptation; Proton therapy; Range uncertainties.
© 2020 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Kesarwala A.H., Ko C.J., Ning H., Xanthopoulos E., Haglund K.E., O’Meara W.P. Intensity-modulated proton therapy for elective nodal irradiation and involvedfield radiation in the definitive treatment of locally advanced non–small-cell lung cancer: a dosimetric study. Clin Lung Cancer. 2015;16:237–244. doi: 10.1016/j.cllc.2014.12.001. - DOI - PMC - PubMed
-
- Ferris M.J., Martin K.S., Switchenko J.M., Kayode O.A., Wolf J., Dang Q. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer. Pract Radiat Oncol. 2019;9:e473–e481. doi: 10.1016/j.prro.2019.04.013. - DOI - PMC - PubMed
-
- Nichols R.C., Huh S.N., Henderson R.H., Mendenhall N.P., Flampouri S., Li Z. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-smallcell lung cancer: a dosimetric study. Clin Lung Cancer. 2019;12:252–257. doi: 10.1016/j.cllc.2011.03.027. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
